Other languages Alvotech

Equities

ALVO

LU2458332611

Real-time Estimate Cboe BZX Other stock markets 19:24:47 21/05/2024 BST			5-day change	1st Jan Change
13.8 ^USD	+3.33%		+0.45%	+16.29%

03:57pm	Alvotech Signs Commercialization Deal for Prolia, Xgeva Biosimilar	MT
03:21pm	Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alvotech Signs Commercialization Deal for Prolia, Xgeva Biosimilar	02:57pm
Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab	02:21pm
Le ultime operazioni dei gestori star	05-20
Die jüngsten Transaktionen der Star-Fondsmanager	05-18
De recentste transacties van de sterbeheerders	05-18
Las últimas operaciones de los gestores estrella	05-17
Les dernières transactions des gérants stars	05-17
Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals	04-30
Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent	04-30
Alvotech Announces U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira	04-30
Cigna to offer Humira rivals with $0 copay at specialty pharmacy	04-25
Alvotech’s Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study	04-24
Alvotech Announces Topline Results from A Confirmatory Clinical Study for AVT05, A Proposed Biosimilar for Simponi	04-24
Alvotech Signs U.S. Agreement to Expand Access for Newly Approved High-Concentration Interchangeable Biosimilar to Humira®	04-19
Alvotech and Teva Announces U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara (ustekinumab)	04-17
J&J beats first-quarter profit estimates on cancer drugs strength	04-16
Alvotech Provides Earnings Guidance for the Year 2024 and 2025	03-21
Alvotech Full-Year 2023 Loss Narrows, Revenue Rises	03-20
Alvotech Reports Earnings Results for the Full Year Ended December 31, 2023	03-20
Alvotech Announces Executive Changes	02-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Alvotech

Equities

ALVO

LU2458332611

Other languages

Filters